Anzeige
Mehr »
Login
Freitag, 18.10.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
5 Millionen Unzen und steigend: NexGold Mining's unerschlossene Goldstraße
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0RE4T | ISIN: US6718071052 | Ticker-Symbol:
NASDAQ
17.10.24
21:22 Uhr
27,160 US-Dollar
+0,360
+1,34 %
1-Jahres-Chart
OAK VALLEY BANCORP Chart 1 Jahr
5-Tage-Chart
OAK VALLEY BANCORP 5-Tage-Chart
GlobeNewswire (Europe)
201 Leser
Artikel bewerten:
(1)

Oak Valley Community Bank: Oak Valley Bancorp Reports 2nd Quarter Results and Announces Cash Dividend

OAKDALE, Calif., July 18, 2024 (GLOBE NEWSWIRE) -- Oak Valley Bancorp (NASDAQ: OVLY) (the "Company"), the bank holding company for Oak Valley Community Bank and their Eastern Sierra Community Bank division, recently reported unaudited consolidated financial results. For the three months ended June 30, 2024, consolidated net income was $5,889,000, or $0.71 per diluted share (EPS), as compared to $5,727,000, or $0.69 EPS, for the prior quarter and $8,404,000, or $1.02 EPS, for the same period a year ago. Consolidated net income for the six months ended June 30, 2024 was $11,616,000, or $1.41 EPS, compared to $17,629,000 or $2.14 EPS for the same period of 2023.

The increase in second quarter net income compared to the prior quarter was due to growth in the deposit and loan portfolios, and an increase in non-interest income. The QTD and YTD decreases compared to the same periods of 2023 were related to an increase in deposit interest expense and general operating expenses.

Net interest income for the three months ended June 30, 2024 was $17,292,000, compared to $17,241,000 in the prior quarter, and $19,407,000 in the same period a year ago. The increase in net interest income over the prior quarter is attributed to loan growth and an increase of 6 basis points in the average earning asset yield. The decrease from the same period a year ago is due to an increase in the average cost of funds to 73 bps for the second quarter of 2024, compared to 16 bps for the comparable period of 2023. The higher interest expense was partially offset by loan growth of $119.5 million over the same period. Net interest margin for the three months ended June 30, 2024 was 4.11%, compared to 4.09% for the prior quarter and 4.45% for the same period last year.

"Our earnings performance reflects our consistent and prudent approach to managing our business. We continue to focus on relationship-based core deposit growth which enables us to maintain our lending activity and enhance profitability," stated Rick McCarty, President and Chief Operating Officer.

Non-interest income was $1,760,000 for the quarter ended June 30, 2024, compared to $1,519,000 for the prior quarter and $1,655,000 for the same period last year. The increases compared to prior periods was mainly due to increased production from our investment advisory service and related fee income.

Non-interest expense totaled $11,616,000 for the quarter ended June 30, 2024, compared to $11,529,000 in the prior quarter and $10,062,000 in the same quarter a year ago. The second quarter increase compared to prior periods is due to general operating costs related to servicing the growing loan and deposit portfolios.

Total assets were $1.84 billion at June 30, 2024, an increase of $34.1 million over March 31, 2024 and a decrease of $21.2 million from June 30, 2023. Gross loans were $1.07 billion at June 30, 2024, an increase of $30.5 million over March 31, 2024 and $119.5 million over June 30, 2023. The Company's total deposits were $1.64 billion as of June 30, 2024, an increase of $32.3 million over March 31, 2024 and a decrease of $37.6 million from June 30, 2023. The deposit increase during the second quarter was due in part to an increase in new checking accounts and their corresponding balances resulting from the new checking acquisition program launched by the bank in January 2024. The deposit decrease compared to the same period a year ago was due to the migration of rate-sensitive deposits, prior to the bank making deposit rate increases in July 2023. Our liquidity position remains strong, as evidenced by $180.3 million in cash and cash equivalents balances at June 30, 2024.

"We are pleased to report another strong financial performance and solid earnings for the quarter. We have achieved steady growth, driven by our ability to meet the needs of our customers and communities," stated Chris Courtney, CEO. "We appreciate the dedication and professionalism of our team members who deliver excellent service to our clients every day."

Non-performing assets ("NPA") remained at zero as of June 30, 2024, as they were for all of 2024 and 2023. The allowance for credit losses ("ACL") as a percentage of gross loans decreased slightly to 1.04% at June 30, 2024, compared to 1.05% at March 31, 2024 and increased from 0.99% at June 30, 2023. The decrease from the prior quarter is due to the growth in outstanding loans. Given industry concerns of credit risk specific to commercial real estate, management has performed a thorough analysis of this segment as part of the CECL credit risk model's ACL computation, concluding that the credit loss reserves relative to gross loans remains at acceptable levels, and credit quality remains stable. As a result, the Company did not record a provision for credit losses during the second quarter.

The Board of Directors of Oak Valley Bancorp at their July 16, 2024, meeting declared the payment of a cash dividend of $0.225 per share of common stock to its shareholders of record at the close of business on July 29, 2024. The payment date will be August 9, 2024 and will amount to approximately $1,881,000. This is the second dividend payment made by the Company in 2024.

Oak Valley Bancorp operates Oak Valley Community Bank & their Eastern Sierra Community Bank division, through which it offers a variety of loan and deposit products to individuals and small businesses. They currently operate through 18 conveniently located branches: Oakdale, Turlock, Stockton, Patterson, Ripon, Escalon, Manteca, Tracy, Sacramento, Roseville, two branches in Sonora, three branches in Modesto, and three branches in their Eastern Sierra division, which includes Bridgeport, Mammoth Lakes, and Bishop.

For more information, call 1-866-844-7500 or visit www.ovcb.com.

This press release includes forward-looking statements about the corporation for which the corporation claims the protection of safe harbor provisions contained in the Private Securities Litigation Reform Act of 1995.

Forward-looking statements are based on management's knowledge and belief as of today and include information concerning the corporation's possible or assumed future financial condition, and its results of operations and business. Forward-looking statements are subject to risks and uncertainties. A number of important factors could cause actual results to differ materially from those in the forward-looking statements. Those factors include fluctuations in interest rates, government policies and regulations (including monetary and fiscal policies), legislation, economic conditions, including increased energy costs in California, credit quality of borrowers, operational factors and competition in the geographic and business areas in which the company conducts its operations. All forward-looking statements included in this press release are based on information available at the time of the release, and the Company assumes no obligation to update any forward-looking statement.

Contact:Chris Courtney/Rick McCarty
Phone:(209) 848-2265
www.ovcb.com
Oak Valley Bancorp
Financial Highlights (unaudited)
($ in thousands, except per share)2nd Quarter1st Quarter4th Quarter3rd Quarter2nd Quarter
Selected Quarterly Operating Data: 2024 2024 2023 2023 2023
Net interest income$17,292 $17,241 $17,914 $18,938 $19,407
Provision for (reversal of) credit losses - - 1,130 300 -
Non-interest income 1,760 1,519 1,755 1,566 1,655
Non-interest expense 11,616 11,529 10,760 10,578 10,062
Net income before income taxes 7,436 7,231 7,779 9,626 11,000
Provision for income taxes 1,547 1,504 1,914 2,272 2,596
Net income$5,889 $5,727 $5,865 $7,354 $8,404
Earnings per common share - basic$0.72 $0.70 $0.72 $0.90 $1.03
Earnings per common share - diluted$0.71 $0.69 $0.71 $0.89 $1.02
Dividends paid per common share$- $0.225 $- $0.160 $-
Return on average common equity 14.19% 13.86% 16.44% 19.85% 23.48%
Return on average assets 1.30% 1.26% 1.27% 1.57% 1.79%
Net interest margin (1) 4.11% 4.09% 4.15% 4.34% 4.45%
Efficiency ratio (2) 59.12% 59.61% 53.08% 49.89% 46.31%
Capital - Period End
Book value per common share$20.55 $19.97 $20.03 $16.29 $17.76
Credit Quality - Period End
Nonperforming assets/ total assets 0.00% 0.00% 0.00% 0.00% 0.00%
Credit loss reserve/ gross loans 1.04% 1.05% 1.07% 1.00% 0.99%
Period End Balance Sheet
($ in thousands)
Total assets$1,840,521 $1,805,739 $1,842,422 $1,835,402 $1,861,713
Gross loans 1,070,036 1,039,509 1,016,579 971,243 950,488
Nonperforming assets - - - - -
Allowance for credit losses 11,121 10,922 10,896 9,738 9,411
Deposits 1,644,748 1,612,400 1,650,534 1,666,548 1,682,378
Common equity 171,799 166,916 166,092 135,095 147,122
Non-Financial Data
Full-time equivalent staff 223 219 222 225 213
Number of banking offices 18 18 18 18 18
Common Shares outstanding
Period end 8,359,556 8,359,556 8,293,168 8,293,468 8,281,661
Period average - basic 8,219,699 8,209,617 8,200,177 8,197,083 8,195,270
Period average - diluted 8,248,295 8,244,648 8,236,897 8,232,338 8,227,218
Market Ratios
Stock Price$24.97 $24.78 $29.95 $25.08 $25.19
Price/Earnings 8.69 8.86 10.55 7.05 6.12
Price/Book 1.22 1.24 1.50 1.54 1.42
(1) Ratio computed on a fully tax equivalent basis using a marginal federal tax rate of 21%.
(2) Ratio computed on a fully tax equivalent basis using a marginal federal tax rate of 21%.
A marginal federal/state combined tax rate of 29.56%, was used for applicable revenue.
SIX MONTHS ENDED JUNE 30,
Profitability 2024 2023
($ in thousands, except per share)
Net interest income$34,533 $38,950
Provision for (reversal of) credit losses - (460)
Non-interest income 3,279 3,310
Non-interest expense 23,145 19,819
Net income before income taxes 14,667 22,901
Provision for income taxes 3,051 5,272
Net income$11,616 $17,629
Earnings per share - basic$1.41 $2.15
Earnings per share - diluted$1.41 $2.14
Dividends paid per share$0.225 $0.160
Return on average equity 14.03% 25.80%
Return on average assets 1.28% 1.86%
Net interest margin (1) 4.10% 4.42%
Efficiency ratio (2) 59.36% 46.31%
Capital - Period End
Book value per share$20.55 $17.76
Credit Quality - Period End
Nonperforming assets/ total assets 0.00% 0.00%
Credit loss reserve/ gross loans 1.04% 0.99%
Period End Balance Sheet
($ in thousands)
Total assets$1,840,521 $1,861,713
Gross loans 1,070,036 950,488
Nonperforming assets - -
Allowance for credit losses 11,121 9,411
Deposits 1,644,748 1,682,378
Stockholders' equity 171,799 147,122
Non-Financial Data
Full-time equivalent staff 223 213
Number of banking offices 18 18
Common Shares outstanding
Period end 8,359,556 8,281,661
Period average - basic 8,214,658 8,189,038
Period average - diluted 8,246,472 8,227,105
Market Ratios
Stock Price$24.97 $25.19
Price/Earnings 8.81 5.80
Price/Book 1.22 1.42
(1) Ratio computed on a fully tax equivalent basis using a marginal federal tax rate of 21%.
(2) Ratio computed on a fully tax equivalent basis using a marginal federal tax rate of 21%.
A marginal federal/state combined tax rate of 29.56%, was used for applicable revenue.

© 2024 GlobeNewswire (Europe)
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.